FOXO4-DRI is a research peptide used in preclinical laboratory models involving metabolic, mitochondrial, immune, or regenerative pathways.

FOXO4-DRI is a synthetic, cell-penetrating research peptide developed for investigational and in vitro research use, designed to modulate protein-protein interactions involving the transcription factor FOXO4. It has primarily been studied in cellular senescence research as a tool to explore how senescent cells maintain survival signaling under stress.

In preclinical and laboratory models, FOXO4-DRI has been examined for its ability to disrupt FOXO4-associated signaling complexes that are linked to pro-survival pathways in senescent cells, with downstream effects that can influence apoptosis-related signaling under controlled experimental conditions. These characteristics have made it a compound of interest in experimental studies focused on senescence biology, stress-response signaling, and pathways associated with cellular aging mechanisms.

Mechanism of Interest

• Angiogenesis: Observed to influence vascular endothelial pathways.
• Tissue Repair: Supports modeling of gastric, tendon, and muscular healing.
• Cytoprotection: Evaluated for protective effects in oxidative environments.

Key Research Applications

• Tissue repair and regeneration research
• Inflammation pathway modeling
• Angiogenesis studies

Research Use Only

This product is supplied strictly for laboratory, research, and development use. Not for human consumption or therapeutic application.